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Background: There are few evidence-based non-pharmacological interventions
adapted for people with dementia (PwD) in lower- and middle-income countries (LMIC).
Thus, there is value in culturally adapting existing interventions from other settings.
One such intervention for PwD involves hearing rehabilitation, which may improve
dementia-related outcomes.
Objective: To culturally adapt and evaluate the feasibility and acceptability of a
multi-faceted hearing support intervention to enhance quality of life in PwD for a LMIC
setting, Pakistan.
Design: This was a study in three phases: (1) training and capacity building to
deliver the study, including Patient and Public Involvement (PPI); (2) cultural adaptation
of the intervention; and (3) delivery of a single-group feasibility study with a pre-test
post-test design.
Setting: Home-based intervention, in two cities of Pakistan.
Participants: Adults aged ≥ 60 with mild-moderate dementia and uncorrected or
partially corrected hearing impairment, and their study partners (n = 14).
Intervention: An adapted hearing support intervention (HSI) comprising a full
assessment of hearing function, fitting of hearing aids, and home-based support from
a “hearing support practitioner.”
Outcomes: Ratings of the feasibility of the study procedures, and
acceptability/tolerability of the adapted intervention were ascertained through
questionnaires, participant diaries, therapist logbooks and semi-structured interviews.
A signal of effectiveness of the intervention was also explored using a battery of
dementia-related outcome measures.
Results: Following cultural adaptation and capacity building for study conduct
and delivery, we successfully implemented all intervention components in most
participants, which were well-received and enacted by participant dyads. Acceptability
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(i.e., understanding, motivation, sense of achievement) and tolerability (i.e., effort, fatigue)
ratings and safety of the intervention were within a priori target ranges. Recruitment and
retention targets required improvement, due to the COVID-19 pandemic outbreak, as
well as the lack of a clear clinical diagnostic pathway for dementia in both sites. Areas
for future modification were clearly identified, including: the assessment/delivery logistics
circuit; procedures for arranging visits; communication among referring clinicians and the
study team.
Conclusion: This is the first study in a LMIC of sensory enhancement to improve
dementia outcomes. Positive feasibility, acceptability and tolerability findings suggest that
a full-scale effectiveness trial, with certain modifications is warranted.
Keywords: dementia, LMICs, hearing impairment, feasibility, acceptability, tolerability
INTRODUCTION
Cognitive decline and dementia are newly emerging as public
health priorities in low- and middle-income countries (LMICs)
due to aging of the population. In South Asia alone, it is estimated
that the number of people who will be living with dementia
(PwD) by 2030 will exceed 9 million (1). Approximately one-
third of adults over the age of 65 years experiences a disabling
hearing loss (2), and in PwD, over 85% are affected (3). Together,
cognitive and sensory deterioration can result in a “crucible of
co-morbidity” for older people, compounding negative outcomes
such as poor quality of life and high caregiver burden (4, 5).
To date, the infrastructure of health and social care services for
older people in South Asia is still quite limited (6, 7). However,
in contrast to dementia services, hearing services are more
developed and there is evidence that improving hearing function
in older people represents a potentially reversible cause of
cognitive impairment, or, may optimize remaining cognitive and
functional ability in people already with dementia (8, 9). Hearing
interventions may promote better outcomes for people with
cognitive impairment, but consistent evidence for the positive
impact is still lacking, highlighting the need for sufficiently
powered randomized controlled trials of such interventions
on outcomes relevant to people living with dementia (8). As
highlighted by recent guidance for up scaling dementia research
in Pakistan (10), developing and evaluating low cost, easily
accessible interventions for PwD and their families in such
low- and middle-income health economies such as South Asia,
is essential to support the development of services. Thus,
addressing outcomes in dementia by improving hearing is an
approach with high potential.
Currently, a large-scale randomized controlled trial (RCT)
of a sensory support intervention for PwD is being conducted
across clinical sites in five European countries (11, 12), as
part of the SENSE-Cog research program (13). The multi-
component intervention involves the assessment, management
of, and adherence support for hearing and vision deficits in PwD.
Early outcomes have indicated that the sensory intervention is
pragmatic and feasible (14) and may be effective in improving
dementia-related outcomes (15). Thus, SENSE-Cog was deemed
a suitable intervention to be evaluated in a South Asian context.
However, since the health and care ecosystem in South Asia
differs from Europe, and public understanding of dementia and
its impact are still developing, it was necessary to undertake
an adaptation and feasibility testing program, SENSE-Cog Asia,
as a first step, prior to a definitive RCT of effectiveness
and implementation.
SENSE-Cog Asia was carried out in three phases, as
outlined in Figure 1. Phase 1 was conducted to build capacity
and capability for applied dementia research in seven sites
across Pakistan (Karachi, Rawalpindi, Lahore), India (Mysuru,
Bangalore, Chennai), and Bangladesh (Dhaka).We have reported
on this work elsewhere (12). Briefly, to develop an integrated
capacity and capability building strategy, we established goals
embedded within a Theory of Change framework (16), across
six domains: people, research integrity and governance, study
delivery skills, international collaborative working, patient and
public involvement (including awareness raising, addressing
social stigma and health literacy), and development of “pathways”
(logistics, referrals, links to existing, or developing services).
Additionally, in Phase 1, we developed a network of patient
and public involvement (PPI) groups to inform the work and
support adaptation of the intervention. The PPI work, which
resulted in a network of people with dementia and their families
(SENSE-Cog Asia Research Advisory Team), involved a variety
of public engagement activities reflecting different parts of
the Wellcome Trust’s “Public Engagement Onion” (17). Each
site reported PPI outcomes, including changing attitudes and
behavior to dementia and research involvement, best methods to
inform participants about the dementia study, sharing knowledge
and outcomes, and co-adapting the dementia study protocol to
the local context. We also reported on the challenges inherent in
introducing a PPI model into LMIC settings where hierarchical
social structures predominate, particularly in the context of
medical professional-patient relationships.
Phase 2 of SENSE-Cog Asia involved cultural adaptation
of the SENSE-Cog hearing and vision intervention, which was
originally developed (4) and field tested (11) in Europe over
18-months. Adapting an intervention developed elsewhere into
a context with a markedly different language, socioeconomic
and cultural context requires modification before it can be
systematically evaluated (18). This enhances the relevance of the
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FIGURE 1 | Flowchart of steps in the SENSE-Cog Asia feasibility study.
intervention to the local population and increases the likelihood
of implementation and “scale-up” following the evaluation stage.
Finally, Phase 3 of SENSE-Cog Asia was initially designed
as a feasibility study of the adapted intervention in all seven
sites across South Asia. The original sample size was chosen
as 70 dyads (PwD and their care partners) (n = 7 dyads from
each site). The focus of the study was to develop and test the
logistics’ circuits of the intervention delivery, other feasibility
parameters, and tolerability of the intervention by participants.
However, following phase 1 and 2, the COVID-19 pandemic
broke out and all research activity stopped. The key challenge
in recruitment was due to the local lockdown in participating
hospital centers in India and Bangladesh due to the pandemic.
However, these sites were also slow to open in the first instance
due to delays in obtaining approvals from local sponsors and the
bureaucracy around transfer of study funds. Only the sites in
Pakistan (Karachi and Lahore), were initiated for the feasibility
study. Thus, we chose to follow current guidance regarding
contingency planning for dementia research in the COVID-19
pandemic (19) and amended our study protocol accordingly to
ensure the safety of our research team and participants. This
involved halting further start-up activity in the remaining sites,
halting recruitment in the Pakistan sites, and completing as
many assessments as possible using remote means. We report
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the outcomes of our amended study, SENSE-Cog Pakistan, here.
Ethical approval for the amended protocol was obtained from
the University of Manchester’s Research Ethics Committee 5
[2019-6061- 9196].
OBJECTIVES
The primary objectives of our amended feasibility study, were: (1)
to describe the baseline characteristics of PwD with concurrent
hearing impairment, and their caregivers in the Pakistan study
sites; (2) to evaluate the feasibility of the operational elements;
(3) to evaluate the acceptability and tolerability of the adapted
intervention for a definitive trial; and (4) to explore the impact of
the intervention on PwD and caregiver outcomes.
Ethical Approval
Since the study was conducted in collaboration with UK-based
investigators, ethical approval was initially obtained from the
University of Manchester’s Research Ethics Committee (REC)
5 [2019-6061-9707]. Local approvals were also obtained at
each site prior to the study commencing. The investigators at
each site ensured that the study protocol and all study-related
documentation was approved by the appropriate REC, prior to
any participant recruitment. All researchers received training in
line with the UK’s Good Clinical Practice (GCP) guidelines (20).
Following the COVID-19 restrictions, ethical approval for
the amended protocol was obtained from the University of
Manchester’s Research Ethics Committee 5 [2019-6061- 9196].
The outbreak of pandemic resulted not only in halting further
start-up activity in the remaining sites, it also halted recruitment
in the two active sites, and the remaining assessments were
completed remotely as much as possible using remote means and
the amended low risk, non-contact intervention was delivered to
the participants who had already consented before the outbreak
of the pandemic.
The biggest ethical challenge for the study related to inclusion
of PwD in a research protocol when they might not have
capacity to consent. Unlike in the UK, where theMental Capacity
Act (2005, amended 2018) has specific legislation to safeguard
research participants lacking capacity, none of the three countries
involved in the original SENSE-Cog Asia protocol has such
legislation. Thus, only participants with capacity were included
in the study.
Equitable Partnerships
Since our work involved close collaboration among investigators
from multiple regions, ranging from high to very low-income
countries, we followed the principles of a “balanced partnership”
to ensure equity in our working relationship (10, 21). Power
imbalances in international research partnerships can occur,
with one partner, usually the partner from the high-income
country (HIC), dictating the terms of the collaboration, and the
other partner being expected to comply (22–24). This risks the
possibility of exploitation and scientific colonialism. In our case,
the intervention originated in Europe and was being adapted
to South Asian settings, adding to the risk of imbalance. Thus,
we strove to ensure equity by: (1) co-developing the study
protocol over 6 months via monthly conferences involving all
team members; (2) incorporating local solutions for intervention
adaptation; (3) ensuring each site’s perspectives were included
through monthly team meetings; (4) incorporating the feedback
from local PPI groups; and (5) sharing of outputs across sites
through co-authorship. This approach fostered mutual respect
and cooperation amongst team members.
METHODS
Phase 1: Capacity and Capability Building
The methods for Phase 1 are described elsewhere (12, 17).
Phase 2: Cultural Adaptation of the
Intervention
Our starting point was the parent form of the intervention, the
SENSE-Cog Sensory Support Intervention (SSI), which as was
developed and field trialed over an 18-month period (4, 8, 11)
and is currently being evaluated in a five-nation definitive RCT
in Europe (4). For the South Asian context, it was important to
consider local factors such as: (1) language and cultural aspects
of participants; (2) availability of resources and services; (3)
understanding and awareness of dementia amongst individuals
and their caregivers; (4) limited recruitment pathways for clinical
dementia research; and (5) limited engagement with dementia
clinical research amongst local clinicians and PwD and their
families. Thus, we modified the intervention for the South
Asian context using a stepwise framework for cultural adaptation
including information gathering, preliminary adaptation of
the study design, and preliminary testing of the modified
intervention (25). The final step, “adaptation refinement” will be
guided by the findings of the feasibility study we describe here.
The first step of information gathering involved a rapid
literature review of existing psychosocial interventions for
dementia in LMICs, followed by PPI consultations with PwD
and caregivers in local contexts, individual consultations with
local dementia and hearing care professionals, and a joint
workshop with core team members of the EU SENSE-Cog
RCT team and the local research teams. Findings from this
work informed initial modifications of each component of the
intervention, as well as aspects of the intervention. In contrast to
the European intervention, the culturally adapted intervention,
or Hearing Support Intervention (HIS) for South Asia included
only hearing support, rather than both hearing and vision
support. Additionally, all assessment and outcome rating tools
were translated into local languages, and the content of the
intervention material was modified to include culturally relevant
pictures and activities and take account of literary levels of
older participants.
Although the Hearing Support Intervention (HSI) that we
developed for the SENSE-Cog Asia trial has core resonances with
the European SENSE-Cog SSI, outlined by Regan et al. (11), it
differed from the European version in several ways including
that we did not specify the make and model of hearing aid that
participants would receive and we included dementia awareness
education for caregivers (Table 1). Moreover, in contrast to the
European version of the study, this was as trial targeting a single
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sensory modality, hearing, only, rather than both hearing and
vision. Additionally, the intervention also included dementia
education and support for the care partner. This was considered
necessary due to the low level of dementia awareness and
cognitive health literary of care partners in Pakistan. A complex
intervention with multiple parts tailored to the needs of each
individual in this context would thus have to include more than
just support for hearing impairment. The approach involved
these elements being closely aligned and inter-dependent. Finally,
our adapted intervention did not include the intervention
components relating to social inclusion, referral to support
services, as these were limited in the regions in which we worked.
We named the intervention provider as a “Hearing Support
Practitioner” rather than a “Sensory Support Therapist” to reflect
the focus on hearing alone and to ensure that cultural concerns
regarding the term “therapist” were avoided.
Phase 3: Feasibility Trial
Study Design and Participants
This was a single arm open-label feasibility and acceptability
study including participant dyads (PwD and their caregiver)
across two sites in Pakistan. Each dyad received the culturally
adapted version of the HSI over an 8-week period, in their own
homes. All participants were assessed for capacity to provide
informed consent to participate in the study, and if deemed
to have capacity, provided written informed consent prior to
their inclusion. Researchers were carefully trained to undertake
capacity assessments in older and potentially vulnerable people.
Additionally, all researchers used a checklist to ensure that the
key elements of capacity to consent were present and recorded.
Inclusion/Exclusion Criteria
As outlined in Table 2, we included people over the age of
60, with capacity to consent, as per the UK’s Mental Capacity
Act, 2005 (amended 2018). All participants had to be living at
home with symptoms meeting criteria for mild-moderate stage
dementia due to Alzheimer disease, vascular dementia or “mixed”
Alzheimer and vascular dementia. Where a formal diagnosis
of dementia was lacking, we included people with evidence of
significant cognitive difficulties (using the informant version of
the GP-Cog) and meeting diagnostic criteria based on researcher
assessment in consultation with clinical expertise from the PI.
All had to have a clinically significant uncorrected or partially
corrected (e.g., outdated prescription for hearing aids) mild to
moderate hearing loss (worse than 35dBHL at 1,000Hz and above
in the better ear). We did not include people with congenital
hearing loss. Study partners were informal caregivers in regular
contact with the PwD (at least three times per week).
Recruitment, Screening, and Sample Size
We recruited and screened potential participants from local
hospitals (medical and psychiatry outpatient departments) and
the community (Alzheimer Pakistan). The agreed sample size in
our amended protocol was 21 dyads (PwD and study partner),
with seven dyads per site to be recruited over 3 months. This
was considered sufficient to evaluate feasibility and tolerability
of the intervention and trial protocol. However, due to the
outbreak of COVID pandemic, the recruitment was halted at
two sites (Karachi and Lahore), and did not begin at one site
(Rawalpindi). At the point of study pause, 23 dyads had been
screened (n = 17 from Karachi, Site A) and (n = 6 from Lahore,
Site B). Fifteen dyads (65%) met study eligibility criteria and
completed baseline assessments (9 dyads from Karachi and six
from Lahore). Participant characteristics are outlined in Table 3.
Of all PwD participants, the mean age of included participants
with dementia was of 66.8± 5.7 years and 9 (39.1%) were male.
Feasibility Study Procedures
Procedures are shown in Figure 1. Following informed consent,
we screened potential participants for hearing and cognitive
impairment using the Sivantos Siemens Hear Check screener
(42) and Urdu-version of the Montreal—Cognitive Assessment
MoCA (26), followed by caregiver screening. For those who
passed screening, a baseline assessment was undertaken, followed
by initiation of the HSI, which was then delivered over eight
visits by the HSP in participants’ own homes. Dyads kept diaries
of each visit, and the HSP kept a logbook detailing visits and
dyad responses.
Evaluation Framework
A priori, we established three possible global outcomes for the
study, based on a “traffic light” system: (1) proceed to a definitive
study; (2) undertake further adaptations and feasibility work; or
(3) do not proceed to a definitive study due to lack of feasibility.
To ascertain this outcome, we designed an evaluation framework
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TABLE 2 | Summary of participant inclusion and exclusion criteria and
characteristics.
Inclusion Age ≥ 60 years
Domiciliary status Living at home
Cognitive
impairment
Diagnosed with dementia as per
ICD10 criteria due to the following
conditions: Alzhemier’s disease (AD)
(as per NINCDS-ADRDA) or vascular
dementia (VAD), or “Mixed” dementia
(AD + VAD) OR evidence of cognitive
difficulties significant enough to
suggest the presence of dementia
without having been formally
diagnosed as having dementia, both
with and without capacity. This will




Dementia in the mild to moderate
stage, as indicated by a Montreal
Cognitive Assessment score (MOCA)
(26) of scale score ≥ 10;
Hearing or vision
impairment or both
Adult acquired hearing Impairment:
defined by a bilateral hearing difficulty,
indicated by failure of a pure tune
hearing screening test in both ears,
defined by hearing worse than
35dBHL at 1,000Hz and above in the





Has capacity to provide informed
consent to participate in the study
defined by the UK’s Mental Capacity
Act (2005)
Study partner is aged ≥ 18 years; and an informal
caregiver (where providing care is not
the person’s primary paid role), such
as a significant other of the PwD (e.g.,
a family member or close friend), who
is either co-resident or in regular
contact (on at least a weekly basis);
Exclusion criteria Hearing Congenital hearing impairments or
has complete deafness (profound
hearing loss) to prevent them from
following study procedures;
General status Any unstable, acute physical or
mental condition that would preclude
participation in the study
Is currently participating in any other




MoCA, Montreal Cognitive Assessment (26).
based on a modified version of the ACCEPT framework (43)
for feasibility studies, which we have previously used in other
studies (44).
Using quantitative measures (Table 4) and qualitative
interviews with participant dyads, outcomes were captured at
baseline, within 1 week of the last intervention visit, and 4–6
weeks after the last intervention visit (for selected measures








Age (Years) Mean (SD) 65.2 (5.5) 30.8 (9.9)
Median (IQR) 64 (8) 29 (10)
Range 60–80 19–55
Gender Female 8 (53.3%) 14 (93.3%)
Male 7 (46.7%) 1 (6.7%)
Duration of cognitive
impairment (months)












Normal (score ≥26) n (%) 1 (4.3%)
Dementia sub-type Alzheimer’s disease 1 (6.7%) Not Applicable
Vascular 1 (6.7%)
Undiagnosed 13 (86.9%)
Living status of PwD Living with spouse 9(60%) Not Applicable




Yes Not Applicable 14 (93.3%)
Hours per week
spent with PwD
Median (IQR) Not Applicable 168 h (24)
Range 15–168 h
MoCA, Montreal Cognitive Assessment (26); SD, Standard Deviation; IQR,
Interquartile Range.
only). At each HIS visit, the PwD and their study partner
completed diaries with in-house Likert-type scales (e.g., rating
each aspect of acceptability and tolerability on a scale of 1 =
strongly disagree to 5 = strongly agree) with space for free text.
Additionally, the HSP completed a logbook and field notes. We
also conducted semi-structured interviews, following a topic
guide, with dyads who completed the intervention (n = 11
dyads), within 1 week of the final intervention visit. The focus of
the interviews was on participants’ perception, experiences, and
acceptance of the HSI. Eight interviews were conducted in Urdu
(national language), and two in Punjabi (local language). All the
interviews were transcribed into Urdu and analyzed to retain the
essence of the themes. Themes were translated into English for
reporting and back translated into Urdu to ensure accuracy.
Feasibility of Trial Procedures
These included recruitment rate, suitability of eligibility criteria,
execution of the “logistics circuit” for assessment and supply of
hearing aids, feasibility of the participant diaries, data collection
methods, suitability of the battery of effectiveness measures,
and retention. Effectiveness measures for the PwD included
ratings of quality of life, mental well-being, neuropsychiatric
symptoms, functional ability (dementia and hearing-related), and
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TABLE 4 | Outcome assessment measures.
Participant with dementia outcomes
Quality of life DEM-QoL
(health-related quality
of life of people with
dementia)
A 28-item questionnaire with options marked on Likert scale from 1 to 4 (a lot/quite a bit/a little/not at all), sum of
all items give total score from 28 to 112, where higher score show better quality of life. Item number 1, 3, 5, 6, and
10 were reversed before final scoring (27).
DEM-QoL-Proxy A 31-item questionnaire with 4 point Likert scale from “1 to 4” (a lot/quite a bit/a little/not at all). Total of all items
give possible score from 31 to 124, higher overall score indicates better quality of life. Item number 1, 4, 6, 8, and
10 were reversed before final scoring. This is answered by carer about PwD (27).
EQ-5D-5L This measures five dimensions of health as mobility, self-care, usual activities, pain/discomfort and
anxiety/depression) on 5 levels. Five levels of problems (no, slight, moderate, severe, extreme) are marked from 1
to 5 that summed for total score ranging from 5 to 25. Low score indicates no problem in health dimensions.
Score measured on Visual Analog Scale (VAS) from 0 to 100, if high indicate the better health state perceived by
the patient. EQ-5D-5L-P is a proxy measure (28).
Short-Form-12 (SF-12) There are 12 categorical items in this tool. These items measured on liker scale as item 1 from 1 to 5 (excellent,
very good, good, fair, and poor), item 2 and 3 from 1 to 3 (limited a lot, limited a little, or not limited at all), item 8
from 1 to 5 (not at all, a little bit, moderately, quite a bit, and extremely), item 9, 10, 11, and 12 from 1 to 6 all of the
time, most of the time, a good bit of the time, some of the time, a little of the time, and none of the time). Item 4 to
5 had yes and no options. Two summary scores are reported from the SF-12—a mental component score
(MCS-12) and a physical component score (PCS-12). SF-12-P is a proxy measure about PwD answered by
caregiver. Higher score indicate better health status (29).
Functional measures The Hearing Handicap
Inventory for the Elderly
(HHIE)
A 25 item tool with 3 response categories (“Yes” = 4, “Sometimes” = 2, “No” = 0). Response of all items added
to get total score from “0 to 100” that categorized functional impermanent as 0–16: “No functional impermanent,”
“17–42: Mild to Moderate” and ≥43: Significant. HHIE–P is a proxy measure answered by carer about PwD
(30, 31).
Activities of daily living
in the elderly
(IADL-EDR)
An 11 item with 3-response category. Each item was rated for its applicability (yes/no), degree of disability (scored
from 0 to 2) and causative impairment (cognitive and/or physical) (32).
Neuropsychiatry
inventory (NPI-12)
A 12 domains tool that assess both severity and frequency of Neuropsychiatric symptoms. Severity ranged as
“mild, moderate and severe” while frequency as “occasional, often, several times per week and once or more
day.” Each domain is rated on presence and magnitude of symptoms (frequency × severity). The maximum score
per domain is 12, with clinically significant symptoms for a given domain occurring at (frequency × severity) scores
≥4. Total NPI scores range from 0 to 144, higher score for both indicate higher severity and more frequency. It is




The Family Care giving
Role scale (FCR)
Consists of 16 items on a five-point scale from 1 to 5, which are divided into three sub-scales: (1) satisfaction with
the caring role, (2) resentment, and (3) anger. A summative score for the items within each sub-scale is calculated






A 30 item tool with 5 point scale from “0 to 4” as “Never, Very rarely, Some days, Most days, and Every day.” Sum
of all items score gave the total score. The FAS was associated with the reported anger, anger expression and
anxiety of respondents and found higher among caregivers (35).
Affiliate Stigma Scale This instrument has 22 items rated on a 4-point Likert scale with three domains (cognitive = 7 items, affect = 7
items, and behavior = 8 items); a higher score indicates a higher level of affiliate stigma (36).
Participant dyad outcomes
Psychological aspects Patient Health
Questionnaire−9
(PHQ-9)
A 9-item tool that record responses from 0 to 3 (not at all to nearly every day). Total score of all items categorized




This has seven items to assess severity of generalized anxiety disorder. The items are scored on 4-point
Likert-scale ranging from 0 “not at all” to 3 “nearly every day.” Scores 5, 10, and 15 signify cut off points for mild,
moderate and severe anxiety, respectively (38).
The De Jong Gierveld
6-item scale loneliness
scale
A 6-item scale with 3 statements about emotional loneliness and 3 about social loneliness. Response categories
for each item are “Yes/More or less/No.” Negatively worded questions are scored “1” for neutral and positive
response while positively worded questions are scored “1” for neutral and negative response. Sum of all items
gave possible score range from “0” least lonely to “6” most lonely (39).




A 12-item tool with responses on a Likert scale from “1” strongly disagree to “5” strongly agree. Sum of the all
even number items indicates patient’s level of Satisfaction With Therapy (ST) and sum of all odd number items
score reflects patient’s level of Satisfaction With Therapist (SWT); higher the score, greater the level of patient




A modified version with six items each with three responses ranges from “1 to 3” (not at all, somewhat, and very).
Sum of the score of all items add up to the final score with possible outcome ranging from “6 to 18” (41).
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relationship satisfaction. Effectiveness measures for the study
partner included ratings of well-being, mental health, caregiving-
related burden and stress, and relationship satisfaction. Since this
was an open-label study, we did not evaluate randomization and
blinding procedures.
Feasibility of the Intervention Components
and Implementation
This was assessed by HSP visit completion rates, visit duration
and HSP logbook feedback.
Acceptability of the Intervention
The appropriateness of the delivery and receipt of the
intervention was determined by percentage dropouts due to
non-acceptability and rate of serious adverse events.
Tolerability of the Intervention
This was operationalized by percentage dropouts due to
intolerance of the intervention and diary ratings of “effort” and
“fatigue.” The criterion for “tolerability” was 75% of participants
scoring the intervention with the a priori target ranges: ≥ 3/5 for
“effort” and “fatigue.”
Semi structured interviews were also conducted with 10 care-
partners who attended the hearing intervention sessions with
PwD. Interviews were conducted to evaluate and gather evidence
for feasibility of the study.
Data Analysis
Quantitative Analysis
As an initial exploration of a novel intervention, our goal was to
observe any signal of change across various outcome measures
in the dyad. We examined the change between baseline (pre-
intervention) and follow-up (post-intervention) by summarizing
the distributions of the outcome measures with measures of
central tendency (mean or median) and variability (SD or IQR).
The small sample size precluded investigation of associations
among outcomes. On initial analysis, the covariates of interest
were not heavily skewed and mean and medians were similar,
thus, we report mean values here.
Qualitative Analysis
The free text feedback of the participant diaries and SST
logbooks, using content analysis (45, 46). The post-intervention
semi-structured interviews with the participant dyads, were
evaluated using thematic analysis (47) which included
familiarization, coding, generating themes, reviewing themes,
defining and naming themes. During the familiarization stage,
transcripts were read by (ST, AQ), and coding was done to
describe the content. Themes were generated by merging codes
into a single theme and reviewed among the researchers (ST,
MR) to ensure there was accurate representation of the data.
Lastly, all themes were defined in order to explain the data. The
whole process was supervised by a senior researcher to minimize
the bias (NC).
RESULTS
Details of the feasibility of trial procedures and acceptability and
tolerability of the intervention are outlined in Table 5.
Feasibility of the Trial Procedures
Recruitment and Retention
Over a 6-month period, we enrolled 15 participant dyads across
two study sites, giving a rate of 2.8 dyads per month, which
was slower than our expected rate of 3.5 dyads per month.
Recruitment was slower than expected in Sites A and B, mostly
due to the Covid-19 pandemic outbreak, which also prevented
Site C from opening. We screened 23 participants dyads across
both sites, 15 participant dyads were eligible to be enrolled in
the study. Of whom two were excluded following a normal
hearing assessment by the audiologist. One participant dyad
withdrew consent following the baseline assessments and one
participant had an adverse event before the follow-up. At Site A,
the reasons for the slow recruitment rate included the retirement
of the referring consultant neurologist and a low number
of older people with memory complaints attending the local
psychiatry outpatient department, which was our main source
of recruitment. Additional recruitment was undertaken from
community health settings, supported by community workers.
At Site B, of the six participant dyads who passed the screening
stage, one withdrew due to an unrelated serious adverse event
in the PwD after completing the baseline assessment. Reasons
for a slower than expected recruitment rate at Site B included:
strikes in hospitals, slow approval process for the study from
local hospitals, lack of memory clinics and specific services for
people with dementia. These factors limited the necessary referral
sources. The overall successful screening rate was 65.2%. The
retention rate at Site A was 83.3% (one PwD died before second
follow-up at site A) and at Site B this was 100%. Screening,
baseline and follow up visits were conducted according to the
protocol across all sites.
Suitability of Eligibility Criteria
The audiologist did not prescribe hearing aids to two participants
who were enrolled in the study. These two participants screened
positive on hearing impairment due to conductive hearing
loss and the need for surgery. This suggested that refinements
to the simple Hear Check hearing screen were needed. All
other inclusion/exclusion criteria were considered as appropriate
by investigators.
Execution of the Service and Device
Logistics’ Circuit
Audiologist visits after baseline assessment were mostly carried
out according to the timeline mentioned in the protocol (i.e.,
71% of participants received their hearing assessment within
2 weeks of the assessment). Nine of the participants received
their hearing devices within 2–3 weeks soon after audiologist
visit. Two participants received their hearing aid within 5 weeks
of the audiology visit because of the adjustments which were
recommended due to severe hearing loss.
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Findings Evidence to support finding





except: (1) cognitive score
cut-offs may be set too high
and exclude PwD who may




15 of those screened met inclusion criteriaa.
Two participants who screened positive on hearing impairment using the Hear Check
were deemed not clinically suitable for hearing aids on full audiological assessmenta,b.
One participant refused to visit audiologist for full assessment
One participant reported an adverse event (not related to study) soon after baseline
assessment (before audiologist visit)
Recruitment:
• Total target number
• Rate
Successful at 11 of 2 sites.
Slower than required for a
larger trial.




Successful in both sites. six completed the study in Sites A; five completed in Site B
Screening & baseline
process:
Appropriate due to the
length of assessment
battery.




Outcome rating scales are
generally acceptable.
Some scales were not
suitable for the study
population and
require revision.
Minimal or no concerns were noted on battery duration and level of difficulty, other
than all two sites reporting problems with:
Details of the scales are in the table above.
Device logistics circuit: Broadly feasible; areas for
improvement identified.
All participantsa received the prescribed hearing aidsb.
Delays in assessment for and receipt of hearing aids affected overall study timelinesa.
Participant diary:
≥ 70% completion
Diary activity was feasible
for both PwD and study
partner.
Out of six participants from site A, five completed their participant diary completely
and one participant completed the diary till 3rd session only as sessions done on
phone due to COVID-19, and participant refused to fill diaryc
out of five participants from site B, one participant’s completed the diary for up to 3
session and two participant’s completed the diary over the phone with the research
assistant due to COVIDc
Feasibility of Intervention components and implementation
HSI:
Was the his delivered,
received and enacted
as intended?
It is feasible, although
timeline deviations were
evident.
10 participants received a hearing assessment within 2 weeks of baselinea,b.
One participant’s hearing assessment got delayed due to operational issues around
audiological assessment
9 participants received their hearing aids within 2–3 weeks and two participants
received these within 5 weeks of their audiological assessment.
All participants completed intervention component of device skills and knowledge
(hearing aids)b






All 11 participants were willing to use their prescribed aidsb
0 participant withdrawals due to lack of acceptability
Tolerability of the intervention by participants
HSI: The intervention is tolerable
All 11 participants were able to complete their hearing assessmenta,b.
The intervention was completed over a maximum of 12–13 visits
Key PwD, Person with dementia; SP, Study Partner; HSP, Hearing support practitioner; aQuantiative data; bHSP logbook; cParticipant dyad diaries.
Usability of Study Materials and Suitability
of Effectiveness Battery
All study measures and materials were feasible and acceptable
to dyads. A total of 11 dyads completed their screening in one
visit and four dyads completed the screening over two visits.
Moreover, six dyads completed baseline assessment in one visit
and 9 dyads completed this over two visits. There was an impact
of COVID- 19 on diary use. Out of the six participants from
site A, five completed their participant diary for all sessions
while one participant completed the diary for only two session,
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as sessions were delivered over phone due to COVID-19, and
participant refused to fill the diary. Whereas, at Site B, four
participants completed their diaries for all the sessions while for
one participant, dairy was completed by the researcher as sessions
were delivered over phone due to COVID-19 and participant was
unable to complete the diary on his own. There were no missing
data on the effectiveness outcome measures.
Feasibility of the Intervention Components
and Implementation
We achieved 100% adherence to the study protocol and
procedure for HSI at both sites. However, there was an increase
in the total number of visits to deliver the intervention mainly
due to the outbreak of COVID-19. All dyads completed their
intervention over a maximum of 12–13 visits. This included a
change from face-to-face to remote delivery of some aspects of
the intervention for one dyad at each site due to the pandemic
and lock down situation.
Acceptability and Tolerability of the
Intervention
At both sites, there were no dropouts or adverse events due to lack
of acceptability of the intervention. Adverse events, which were
all unrelated to the intervention, included: death due to heart
failure (n = 1), fall out of bed (n = 1), and hospital admission
due to fever (n= 1).
Exploratory Effectiveness Outcomes
Measuring cognition, the most common primary outcome for
dementia trials, was deemed not feasible as our study population
had varying levels of literacy. Instead, we based our outcomes on
a large-scale consultation exercise of meaningfulness of outcomes
of non-pharmacological interventions for people living with
dementia. This consultation, which involved multiple lay and
professional stakeholders, de-prioritized cognitive outcomes and
focused more on quality of life and engagement as important
outcomes. Furthermore, according to our hypotheses and
previous evidence syntheses (8), we did not anticipate that our
intervention would significantly impact on cognitive outcomes
but would instead have impact non-cognitive outcomes.
Participants With Dementia
Scores on effectiveness measures at baseline and post-
intervention are outlined in Table 6. Overall, improvements
were seen in several dementia-related outcomes following the
intervention, compared to baseline.
Quality of life as assessed by the DEMQOL [health-
related quality of life of people with dementia; (27)], showed
improvement of mean score from baseline (49.9 ± 4.9) to first
follow-up (65.0± 10.0), which was maintained at second follow-
up (65.3 ±15.9) 4 weeks later. The DEMQOL-proxy, which
assessed quality of life of the PwD as perceived by the caregivers,
also showed a 15.2 point improvement in score from baseline
(61.7 ± 11.7) to post intervention follow up (78.1 ± 7.9) that
was also maintained at second follow up point (81.0 ± 11.09)
(seeTable 6). Mean health status, as measured by EQ-5D-5L (28),
showed improved quality of life at post intervention with 1.7
point reduction in mean score from baseline to post intervention
(i.e. from 14.4± 3.7 to 13.5± 4.9), while the Visual Analog Scale
(VAS) score increased from 42.7± 17.2 at baseline to 47.7± 18.5
at follow up, suggesting improvement in health status. The EQ-
5D-5L Caregiver proxy mean scores (28) at the time of baseline
indicated average quality of life. Both summary scores from
the Short-Form-12 [SF-12, (29)], the physical component score
(PCS-12) and the mental component score (MCS-12), showed
improvement PCS andMCSmean scores increased from baseline
(26.7 ± 4.9 and 34.0 ± 6.8) to post intervention follow up (29.5
± 5.2 and 40.0± 10.2), respectively.
Functional Measures
Of the 15 participants who completed the baseline measures,
14 (93.3%) had significant impairment and one had mild to
moderate impairment on the Hearing Handicap Inventory
for the Elderly Screening tool [HHIE; (30, 31)] at baseline,
whereas following the intervention, none reported significant
impairments on this scale, and two reported moderate
impairment, reflecting an overall improvement in hearing-
related functional impairment. As shown in Table 6, no changes
in instrumental activities of daily living [IADL-EDR scale;
(32)] were noted including in the sub-components of the
scale. Neuropsychiatric symptom load diminished significantly
from pre- to post-intervention (29.3 ± 20.1 to 9.8 ± 8.8)
on the Neuropsychiatric Inventory [NPI, (33)]. Additionally,
the proportion of behavioral domains which were scored in
the “clinically significant” range (≥4 on frequency x severity)
following the intervention at follow-up one was significantly
lower compared to the proportion at baseline. There was a
reduction in mean depression scores on the Patient Health
Questionnaire−9 (PHQ-9, 44) from baseline (17.6 ± 3.8) to
the first post intervention follow up (11.5 ± 3.7) of more than
6 points on the scale, which is greater than the minimally
important clinical difference and was maintained at second
follow-up (12.3 ± 4.7). On this same measure, severe depression
was found among five (33.3%) participants at baseline that
was not present in any of the participant post intervention
(Table 6). Generalized Anxiety Scale-7 [GAD-7, (38)] showed
a seven-point reduction in anxiety from baseline (14.2 ± 4.4)
to post intervention (6.9 ± 2.9); this improvement was also
sustained at second follow up (8.4 ± 4.0). Severity of anxiety
also reduced from 10 (66.7%) at baseline to minimal anxiety at
post intervention follow up (Table 6), as did loneliness scores, as
assessed by De Jong Gierveld Loneliness Scale (39).
Caregiver Outcomes
Caregiver measures at baseline and post-intervention are
outlined in Table 7. Overall, as with the participants with
dementia, improvements were seen in a number of outcomes
following the intervention, compared to baseline. Caregiver
burden and stress reduced from baseline to second follow-up, as
by an absolute 5.1-point increase in the satisfaction mean score
on the Family Caregiving Role scale [FCR; (34)]. Depression
and anxiety improved following the intervention, as shown
mean score reduced from baseline (9.4 ± 5.9 and 7.2 ± 5.7)
to post intervention (7.7 ± 7.0 and 4.5 ± 3.5) and second
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49.9 ± 4.9 65.0 ± 10.0 13.2 ± 9.2 65.3 ± 15.9 13.1 ± 18.2
Median (IQR) 49 (5.5) 64 (13) 13 (5.5) 61.5 (13.5) 11 (19)
(Range) (44–61) (53–84) (−2 _30) (41_96) (−14_48)
DEM-QOL-proxy
Mean ± SD 61.7 ± 11.7 78.1 ± 7.9 15.2 ± 17.3 81.1 ± 11.7 14.8 ±17.7
Median (IQR) 64 (17) 76 (8) 6 (28) 85 (15) 11.5 (27.5)
(Range) (35–78) (66–94) (−3_42) (58–93) (−10_39)
EQ-5D-5L
Mean ± SD 14.4 ± 3.7 13.5 ± 4.9 −1.7 ± 4.4 Not
applicable
Median (IQR) 15 (6) 13 (4) −3 (1.5)
(Range) (8–19) (7–25) (−5_11)
VAS Score
Mean ± SD 42.7 ± 17.2 47.7 ± 18.5 6.8 ± 24.2
Median (IQR) 45 (20) 50 (12.5) 15 (15)
(Range) (5–70) (10–75) (−55_25)
EQ-5D-5L-proxy
Mean ± SD 13.8 ± 3.7 12.6 ± 4.7 −1.9 ± 3.2 Not
applicable
Median (IQR) 15 (5.5) 12 (7) −3(2.5)
(Range) (7–19) (6–22) (−6_4)
VAS score
Mean ± SD 53.3 ± 19.6 48.2 ± 12.9 −5.5 ± 25.1
Median (IQR) 55 (27.5) 50 (17.5) 5 (45)
(Range) (20–80) (25–75) (−40_30)
SF-12 PCS
Mean ± SD 26.7 ± 4.9 29.5 ± 5.2 3.4 ± 6.1 Not
applicable
Median (IQR) 26.4 (5.8) 29.5 (10) 2.7 (8.7)
(Range) (19.6–37.5) (23.2–36.2) (−6.7_13.9)
SF-12 MCS
Mean ± SD 34.0 ± 6.8 40.0 ± 10.2 4.9 ± 9.3 Not
applicable
Median (IQR) 33.6 (5.3) 42.9 (14.8) 6.2 (9.5)
(Range) (25.4–50.4) (22.3–54.2) (−12.7_21.5)
Functional measures
HHIE
Mean ± SD 66.7 ± 17.9 11.6 ± 10.5 54.5 ± 21.6 Not
applicable
Median (IQR) 70 (30) 8 (8) 56 (24)
(Range) (36–92) (00–32) (4–80)
Functional Impairment n (%)
No 0 9 (82%)
Mild/moderate 1 (6.7%) 2 (18%)
Significant 14 (93.3%) 0
IADL-EDR
CD 9.5 ± 3.0 8.1 ± 3.1 1.0 ±4.8 Not
applicable
(Continued)
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10 (1.5) 9 (2.5) 0 (4)
(2–16) (1–11) (−9_9)
PD 2.4 ± 2.6 3.7 ± 3.8 −1.2 ± 3.0
Mean ± SD 2 (4) 3 (7) 0 (1.5)
Median (IQR) (0–7) (0–10) (−9_3)
(Range)
NPI-12
Total Score 29.3 ± 20.1 9.8 ± 8.8 19.5 ± 11.3 7.7 ± 8.5 21.6 ± 11.6
Mean ± SD 22 (21) 8 (18) 14 (25) 8 (13) 16 (24)
Median (IQR) (8–87) (0–24) (−5_70) (0–27) (−8_87)
(Range)
Delusions 1.7 ± 2.7 00 1.7 ± 2.7 00 1.7 ± 2.7
Hallucinations 0.9 ± 2.1 00 0.9 ± 2.1 00 0.9 ± 2.1
Agitation 2.3 ± 2.6 0.5 ± 0.7 1.7 ± 1.9 0.5 ± 0.7 1.8 ± 1.9
Depression 5.5 ± 3.8 1.8 ± 1.8 3.7 ± 2.0 1.6 ± 1.8 3.9 ± 2.0
Anxiety 4.1 ± 3.3 1.1 ± 1.1 2.9 ± 2.3 0.8 ± 1.0 3.3 ± 2.3
Elation 0.9 ± 2.2 00 0.9 ± 2.2 00 0.9 ± 2.2
Apathy 2.3 ± 2.1 0.7 ± 1.0 1.6 ± 1.1 0.9 ± 1.8 1.4 ± 0.3
Disinhibition 1.5 ± 2.5 0.2 ± 0.6 1.3 ± 2.0 0.2 ± 0.6 1.3 ± 2.0
Irritability 3.4 ± 3.5 0.9± 1.6 2.5 ± 1.8 0.8 ± 1.7 2.6 ± 1.8
Aberrant motor
behavior
1.3 ± 2.2 1.2 ± 1.7 0.1 ± 0.4 0.5 ± 1.1 0.7 ± 1.1
Sleep 4.2 ± 4.3 2.7 ± 2.9 1.5 ± 1.4 2.0 ± 2.4 2.2 ± 1.9




Mean ± SD 17.6 ± 3.8 11.5 ± 3.7 6.0 ± 3.7 12.3 ± 4.7 4.7 ± −5.1
Median (IQR) 18 (5.5) 11 (5) 4 (3.5) 11 (5.8) 3.5 (5.8)
(Range) (11–23) (7–18) (2–14) (7-21) (−2_14)
n(%)
Mild 0 4 (36%) 5 (50%)
Moderate 3 (20%) 5 (45%) 2 (20%)
Major 7 (46.7%) 2 (18%) 2 (20%)
Severe 5 (33.3%) 0 1 (10%)
GAD-7
Mean ± SD 14.2 ± 4.4 6.9 ± 2.9 7.1 ± 3.8 8.4 ± 4.0 4.7 ± 4.5
Median (IQR) 15 (5) 6 (4) 7 (6) 9 (6.5) 3.5 (5.5)
(Range) (6–20) (2–11) (2–13) (2–14) (−1_13)
n(%)
None 0 2 (18%) 2 (20%)
Mild 3 (20%) 6 (55%) 3 (30%)
Moderate 2 (13.3%) 3 (27%) 5 (50%)




4.9 ± 1.1 4.4 ± 1.8 0.7 ±−1.8 Not
applicable
Median (IQR) 5 (2) 5 (1.5) 0 (1.5)
(Range) (3–6) (1–6) (−1_4)
(Continued)
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Dem-QOL(-P), dementia quality of life (-Proxy) (27); EQ-5D-5L, EuroQol Five Dimensions Five Levels (28); VAS, Visual Analog Scale (28); SF-12 (-P), 12 Item Short Form Survey (-Proxy)
(29); PCS, physical component score (29); MCS, mental component score (29); HHIE, Hearing Handicap Inventory for the Elderly Screening tool (30, 31); IADL-EDR, Instrument of
Activities of Daily living in the elderly (32); NPI-12, Neuropsychiatric Inventory 12 (33); PHQ-9, Patient Health Questionnaire-9 items (37); GAD-7, Generalized Anxiety Scale-7itmes (38);
STTS-R, Satisfaction with Therapy and Therapist Scale-Revised (40); MCEQ, Modified Credibility and Expectancy Questionnaire (41).
time follow ups (5.0 ± 2.2 and 3.5 ± 1.9) on the PHQ-9 and
the GAD-7, respectively. Severe anxiety was found among two
(18.2%) caregivers that reduced significantly at both follow ups.
In contrast to loneliness scores among participants in dementia,
mean loneliness scores increased among caregivers from baseline
to follow up (Table 7).
Knowledge and awareness of dementia, as reflected by
the Family Attitude Scale [FAS; (35)] score among caregivers
increased from baseline (37.1 ± 1.9) to post intervention
follow up (44.0 ± 16.4), reflecting a possible improvement in
attitudes. On the Survey of Attitudes to and Knowledge of
Dementia (48) caregivers showed an increase in score from
baseline (22.0 ± 3.2) to post intervention follow up (34.5 ± 4.6).
Finally, on the Affiliate Stigma Scale (36), initially developed to
assess the self-stigma of a caregiver providing care to a family
member with a mental illness or intellectual disability and now
adapted for dementia, the mean score on all three elements
(cognitive, affective and behavior), increased from baseline to
post intervention follow up, indicating an increase in caregivers’
perceived stigma related to dementia in the person they cared for.
Process Measures
As shown in Tables 6, 7, high levels of satisfaction with both
the intervention and the therapist [Satisfaction with Therapy and
Therapist Scale-Revised; (40)] were reported by the participant
and caregivers, respectively.
Qualitative Findings
As shown in Table 8, seven main themes emerged from the
thematic analysis of the semi-structured interviews. These were:
motivation for participation in the study, views regarding the
intervention, impact of the intervention on the participant with
dementia and their caregiver, challenges faced due to hearing
impairment, understanding of dementia, pathways to care in
Pakistan and views regarding the therapist. Table 8 includes
exemplar quotes from participants supporting each theme.
Regarding participants’ understanding of dementia, analysis
of the interviews suggested that “brain weakness,” in terms
of memory, and emotional distress were considered part of
a dementia syndrome. Participants reported that dementia
involved memory impairment and impacted on the ability to
undertake basic daily tasks. They recognized that help could be
sought from “brain doctors,” including psychiatrists; however,
participantsmentioned barriers in help seeking included the need
to undertake household chores, lack of time and encouragement
from other family members to take the affected person for
appointments, and forgetting to attend appointments.
Caregivers also reported that they gained much knowledge
and awareness about dementia and the impact of sensory
impairments on the person with dementia’s ability to function
well. They improved their understanding of hearing aids and
felt confident to provide explanations or help others facing
same issues. Caregivers also discussed the impact of hearing and
memory problem on the mood of the person with dementia and
how this fostered family disputes; using hearing aids resulted in
improvements inmood and emotional interactions among family
members. This echoed the quantitative findings of improved
mood, anxiety level and behavioral disturbance seen in the
effectiveness outcomes post-intervention.
Participants reported that overall, the intervention was
feasible and effective in improving quality of life of the participant
dyads. The hearing aids came as a solution to their hearing
problem and improved communication, increasing the ability
of those with dementia to participate more in daily activities
and family interactions. This was reflected in the reduction in
loneliness scores in the participants with dementia, as rated
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TABLE 7 | Baseline and post-intervention outcome measurements for the caregivers.














Caregiver-related burden and stress
FCR
Mean ± SD 51.5 ± 8.5 52.9 ± 8.8 1.6 ± 9.2 55.9 ± 8.2 5.1 ± 8.2
Median (IQR) 50 (9) 51 (4) 0 (10) 54.5 (7.5) 2.5 (7.5)
(Range) (40–68) (45–77) (−17_17) (44–71) (−5_21)
Knowledge and awareness of dementia
FAS
Mean ± SD
38.9 ± 6.8 44.0 ±16.4 −6.9 ± 17.3 Not
applicable
Median (IQR) 38 (5.5) 40 (6.5) −3 (5.5)
(Range) (25–52) (33–92) (−52_14)
Attitude and knowledge of dementia
Mean ± SD 22.0 ± 3.2 34.5 ± 4.6 11.8 ± 4.6 Not
applicable
Median (IQR) 23 (3) 35 (8.5) 14 (8)
(Range) (14–26) (27–40) (4–18)
Affiliated stigma scale (39)






























9.4 ± 5.9 7.7 ± 7.0 1.5 ± 7.0 5.0 ± 2.2 4.5 ± 6.0
Median (IQR) 8 (9.5) 5 (4) 1 (7.5) 5 (2.5) 3.5 (3.4)
(Range) (2–19) (2–27) (−9_14) (1–8) (−3_18)
n(%)
None 2 (18.2%) 4 (36.4%) 4 (40%)
Mild 5 (45.5%) 5 (45.5%) 6 (60%)
Moderate 2 (18.2%) 1 (9.1%) 00
Moderately Severe 2 (18.2%) 00 00
Severe 00 1 (9.1%) 00
GAD-7
Mean ± SD 7.2 ± 5.7 4.5 ± 3.5 3.1 ± 5.0 3.5 ± 1.9 4.3 ± 6.3
Median (IQR) 6 (7.5) 3 (2.5) 2 (4) 4 (3) 3 (9)
(Range) (0–17) (1–14) (−4_13) (1–6) (−4_14)
n(%)
None 3 (27.3%) 7 (63.6%) 5 (50%)
Mild 5 (45.5%) 3 (27.3%) 5 (50%)
Moderate 1 (9.1%) 1 (9.1%) 0
Severe 2 (18.2%) 0 0
De Jong Gierveld loneliness scale
Mean ± SD 3.6 ± 2.1 4.2 ± 1.7 0.6 ± 2.3 Not
applicable
(Continued)
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Median (IQR) 4 (3.5) 3 (2) 2 (3.5)





























FCR, The Family Care giving Role scale (34); FAS, Family Attitude Scal (35); PHQ-9, Patient Health Questionnaire-9 items (37); GAD-7, Generalized Anxiety Scale-7itmes (38); STTS-R,
Satisfaction with Therapy and Therapist Scale-Revised (40); MCEQ, Modified Credibility and Expectancy Questionnaire (41).
on the loneliness scale. Finally, caregivers reported that they
appreciated the way the HSP delivered the intervention and felt
that the mode of delivery was clear and acceptable.
DISCUSSION
This is the first reported study of a sensory support intervention
for people living with dementia and their caregivers in a
LMIC. Non-pharmacological interventions that are accessible,
acceptable and affordable, such as the intervention trialed here,
have the potential to positively impact the lives of people
with dementia and their families, particularly in settings where
resources and health literacy for dementia are low. Here, we
demonstrated that a home-based hearing and dementia support
intervention is feasible, well-tolerated, and acceptable. We also
showed that the study procedures were generally feasible,
with some modifications, and that the battery of effectiveness
measures, were acceptable to participants, had minimal missing
data and showed a signal of change pre- and post-intervention.
The carefully adapted intervention activities and material were
culturally appropriate and received well by the participants. Thus,
our findings suggest that a full-scale effectiveness trial, with
certain modifications, is achievable, according to our a priori
“traffic light” criteria. Additionally, this type of study fits well with
the applied dementia research agenda in Pakistan (10).
Key areas requiring modification included the need to
improve recruitment rates and referral pathways into the study.
Finding appropriate services supporting people with dementia
proved challenging since the health and care ecosystem for
older people’s health, particularly for dementia is still developing.
Indeed, it was only in 2019 that the country’s first official
Memory Clinic was opened in the Punjab, in Lahore (verbal
communication). As outlined in the “Roadmap for developing
dementia research in Pakistan” (10), undertaking applied
dementia research alongside service development is essential to
ensure the most appropriate, effective and contextually relevant
services are put in place. Thus, for dementia research to develop
and provide the necessary evidence-base to improve the lives of
people with dementia in Pakistan, services and care pathways for
dementia need to develop in parallel.
Interestingly, findings from the qualitative interviews revealed
that while aspects of participants’ understanding of dementia
were present, seeking help and support was not prioritized,
and barriers such as household chores and “forgetting the
appointment” were cited as reasons for not attending clinics.
Advances such as the development of a National Dementia Plan
in Pakistan (verbal communication, H. Jafri) may help to raise
the profile of dementia and support public understanding of the
need to seek help and support for a condition that is outside of
the normal aging process.
The first phase of the study involved developing the capacity
and capability at an individual and team level. This resulted
in upskilling new researchers and fostering a research culture
in a LMIC-setting with hither to limited experience in older
adult clinical research (49). This stage of the work was crucial
to prepare the way for a subsequent definitive intervention.
Additionally, part of phase one involved recruiting a PPI group
in several study sites. This work reported elsewhere (17), was a
key element in supporting the cultural and contextual adaptation
of the intervention, which was initially developed in Europe for
EU settings, which are markedly different to Pakistan and other
South Asian settings. The experience of PPI was also unique,
since PPI is not well-known nor practiced beyond certain HIC
(mostly English-speaking) countries and, moreover, we involved
people with dementia and their caregivers. PPI involving in
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TABLE 8 | Qualitative findings.
Main theme
Motivation behind participation
The motivation for most participant dyads to
participate in this study was to find a solution of
the difficulties associated with hearing and
memory impairment. However, due to lack of
awareness some participants were initially
hesitant to join the study
Reason for participation
My mother has hearing impairment and she always gets upset about it. When we try to talk to her, she is unable to
hear us. So to make it easier for her we joined the study(PT002)
At first I got worried because I was unable to hear what the doctor was saying to me when he came home but she
was so nice and dealt with me in such a nice way that made me feel really good later on (PT010)
Views regarding Intervention
Hearing intervention was perceived as
acceptable, feasible, easy to understand and
useful by PwD. Dyads took interest in all
sessions and reported improvement in PWD.
There were no adverse event related to the
intervention
Acceptability, feasibility & tolerability
It felt good when I realized that you have solved my mother’s problems by coming to our house and talking to us
and giving us hearing aids. It really feels like most of her problems are resolved. It had made us all so happy
(PT01).
We were not aware that hearing aids can be so useful and they can make the life of the person with hearing
impairment so much easier. In fact not only for them, for all of us. Like for any other illness there is a cure and
hearing aids are the cure for hearing impairment. It made us feel good and very happy (PT03).
One session got delayed because my mother-in-law was not well, otherwise it was all good (PT06).
After the intervention she was 100% confident in using them and she used them easily (PT04).
Impact of intervention on PWD
Care-partners coded hearing intervention as
effective, in improving PWD’s quality of life,
mood, social relationships and self-concept.
Improved quality of Life
Before getting the hearing aids and the training on how to use them, she used to disturb me all the time even at
nights by calling my name very loudly but now she keeps herself busy in different things such as interacting with
other people in the family and her friends. She also tries to take care of the loved ones around her. I have even
noticed her memory has improved considerably which is making her feel better in herself. The hearing aids you
have given are also very advantageous and she is coming back toward life (PT05).
Improved Self Concept She started to have an inferiority complex, along with negative thoughts all the time considering hearing
impairment as a disability but now that its fixed, my mother’s mind stays fresh, she is finding it easy to keep herself
busy in doing one thing or another around the house (PT01).
Improved social relations Due to the hearing impairment she started losing interest in social interaction, because it was very difficult for her
to talk to someone, but now this device helps a lot and she started interacting with the people again. She also
attend different events and gathering in the family now (PT09).
Improved Mood She used to be very irritated and angry most of the time but now she stays calm. It makes us happy. I also feel fine
most of the time now (PT03).
Before the death of my father in law, she used to have chickens and their cage but after he passed away, she
removed the cage. The therapist advised a cage and me to get few chickens again for my mother in law. I cannot
believe how busy she keeps herself to take care of them now. She even help me taking care of my younger child
sometimes (PT05).
Impact of intervention on Care partners
Care-partners also coded hearing intervention
as a source for improving/increasing their
knowledge, attitude and practices toward
dementia. Along with overall impact on their
mood, quality of life, and care burden.
Improved knowledge, attitude and Practices
The therapist taught us really good communication skills. She advised us to make sure there is enough light so the
PwD can see our face when we talk to them. She also advised us to keep PwD company as much as we can so
their mind is occupied with the conversation. Yes the therapist gave us really useful tips to deal with the PwD
(PT01).
I used to think that she was doing everything intentionally but the therapist guided me about her problem and
advised me that in this age group, people have this problem but the machine (hearing aid) you gave is very useful.
I got a lot of relief (PT05).
I think I did not have awareness. But now I have a comprehensive guideline that how these things interlink and
how to deal with all this (PT10).
Mood No no, as I explained before that my mind becomes like that, I get irritated sometimes. Otherwise their explaining (I
am thankful to God) was very good, there was no problem, and everything was fine (PT01).
Quality of Life He is much better than before. Both me and my husband were so worried before but now it is much better (PT08).
I got a lot of knowledge about how to talk with people who have hearing problem and it has given me confidence
that I am able to talk to those people and also help them in day to day life (PT09).
Care Burden The burden of my father’s responsibility is less now. Now he takes care of himself and I can focus more on
different chores around the house (PT04).
Stress which I used to have 24 h is relieved (PT10).
Challenges faced due to hearing problem
Hearing problem, highlighted as a main dispute
reason between family member and PwD
effecting everyone’s life with prominent feeling
of loneliness in PWD
Disputes
Before we had to keep repeating ourselves, and she never really liked anything that I do. Always complaining
about me doing everything wrong. I have a small kid and there are so many chores around the house, if she call
me repeatedly, how am I supposed to finish my work. She always used to call me when I was doing some
important chore and then complaining that I don’t respond. This was the main reason of our arguments (PT02).
Loneliness She used to feel very sad, thinking she is becoming a burden and getting stressed about it. Mostly when we try to
talk to her, she prefers to stay quiet (PT01).
(Continued)
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TABLE 8 | Continued
Main theme
What is Dementia?
Care partners came up with different examples
which they were observing in their family
member such as forgetting about things, name
of the people in the family, not being sure if they
had their dinner or not. These were the main
symptoms that their brain was getting weak
and they are having memory problems.
Care-partner’s also believed that both memory
and hearing problem are interlinked and
impacting one another.
Knowledge Regarding Dementia
My mother in law always seem to forget if she had her dinner or not. When we had guests over, she asked who
those people are although it was her own daughter. She doesn’t remember when I came even though I stayed
with her 15 days. Like did I come on Wednesday or Thursday, she forgets (PT03).
Brain becomes weak so they forget where they put things. This causes stress and depression as well (PT06).
Stress is the biggest cause (PT01).
I think both things were important and may be if there was no device (hearing aid) we wouldn’t come to know
what is affecting him as he used to become angry when he can’t hear or remember something. I think both things
are connected (PT10).
Pathways to care
“Neurosurgeons” and “psychiatrists” were
highlighted as person to contact for memory
issues. Along with lack of family support as
hurdle in accessing this.
Pathways
People do things like take them to neurosurgeons or psychiatric hospitals because they have a brain problem,
puts things somewhere and forgets. (PT01)
Barriers in Pathways to Care There is either stress or a lot of house chores, that is why we forget, that is why family members avoid taking them
to see a doctor. I am talking about myself (PT09).
Views regarding therapist
According to the care-partners, sensory
support therapist were very cooperative and
empathetic. They guided them in such an
easier way that it was easy to comprehend and
can be understandable to anyone.
Feedback about the therapist
The therapist guided us properly and listened to us actively and gave us respect (PT05). She speaks very well, she
was very responsible, I mean she empathized our pain (PT08).
this population is still in its nascent phases, even outside LMIC
settings (50).
Another key challenge we faced in our study was the Covid-
19 pandemic which arrested clinical research in all settings.
We had initially planned to conduct our feasibility study in
seven sites in three South Asian countries. However, due to
the pandemic, we were only able to conduct the study in
two sites in Pakistan, resulting in low numbers of participants
and findings from only one South Asian country. We were
also required to adapt our protocol to minimize face-to-face
assessments. Since few of our older participants had access to
online or other remote means of communication, we had to
undertake telephone assessments. Despite the challenges, we
were able to complete the study according to the amended
study protocol, achieve an acceptable retention rate of the
participants, and glean meaningful results to inform the next
stage of our work.
Aside from our main finding that the study procedures
and intervention were feasible and acceptable by people with
dementia and their caregivers in Pakistan, we also found that
the intervention appears to improve quality of life in people with
dementia, and may have a role in improving functional ability
and reducing behavioral and psychological symptoms associated
with dementia. These findings are in line with Dawes et al. (8)
and suggest the need of properly powered control trial of similar
hearing intervention. A fully powered sample will also help us
further understand the mechanisms of the hearing-cognition
relationship (51). Moreover, in caregivers, care burden, distress
and depression appeared to improve following the intervention.
Results from this feasibility study apply to participants with
dementia who have cognitive capacity to provide consent.
Feasibility and results for participants with more severe dementia
is unknown, particularly as the intervention involves hearing
aids (not simpler amplification devices).The outcomes were
supported by the qualitative findings from our participant dyads.
However, contrary to expectation, affiliate stigma appeared to
increase following the intervention, likely due to a greater
understanding of the condition of the person being cared for.
This suggests that care is needed when increasing awareness and
educating family members about dementia as being outside the
sphere of normal aging. It is important to mention that while
interesting, our findings need to be interpreted with significant
caution as the sample size was small, the study was uncontrolled,
and the intervention and outcome ratings were not blinded.
Nonetheless, finding a signal of change is promising and supports
the need to further investigate effectiveness in a fully powered
sample, with consideration given to implementation in real
life settings.
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